Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.
BACKGROUND
Polypharmacy is common in outpatients and has been identified as a major risk factor for drug-drug interactions (DDIs), which are an important cause of adverse drug reactions. There has been a rapid increase in the number of elderly patients worldwide. However, there have been few studies quantifying the impact of both patient age and the number of concomitant drugs prescribed on the probability of potential DDIs per person in general outpatients.


OBJECTIVE
To assess the extent to which polypharmacy and aging are associated with potential DDIs in outpatients at a medical centre in Taiwan.


METHODS
The medications of 81,650 outpatients who visited a medical centre in Taiwan between January 2004 and March 2004 were retrospectively screened for potential DDIs using a computerized drug-interaction program. The main inclusion criteria were a minimum of two drug prescriptions and duration of use of 14 or more days. We also analysed the DDI pattern, which included severity, level of documentation and onset of potential DDIs, and assessed the impact of the number of drugs prescribed and of aging on the prevalence of potential DDIs per person.


RESULTS
The prevalence of potential DDIs was 25.6% (20,902 of 81,650). The mean ± SD age of the 20,902 patients with potential DDIs was 57.5 ± 16.5 years, and 47.6% of these patients were male. The mean ± SD number of prescribed drugs in patients with potential DDIs was 5.8 ± 2.4, and 67.7% of these patients were prescribed more than four drugs. The majority (55.7%) of DDIs were of the C2 pattern (severity: moderate; documentation: probable). The prevalence of potential DDIs increased in a linear mode with increasing age (p < 0.001) and with the number of drugs prescribed (p < 0.001); furthermore, in addition to being independently associated with potential DDIs, these two factors interacted to increase the risk further.


CONCLUSIONS
This study showed that approximately one-quarter of 81,650 outpatients who visited a medical centre in Taiwan over a period of 3 months in 2004 had potential DDIs. We observed independent increases in potential DDIs per person in association with aging and increasing number of prescribed drugs. Furthermore, a significant interaction between these two factors was observed: the effect of aging on the prevalence of potential DDIs increased as the number of prescribed drugs increased. Potential DDIs in outpatients can be reduced by minimizing the number of drugs prescribed following careful consideration of both their benefits and risks, particularly in the aging population.
Department of Pharmacy, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
Chen-Fang
CF
Lin
Chun-Yu
CY
Wang
Chyi-Huey
CH
Bai
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000502:physiology*; D002648:Child; D002675:Child, Preschool; D019295:Computational Biology / Q000379:methods*; D004347:Drug Interactions / Q000502:physiology*; D005260:Female; D006306:Health Surveys / Q000379:methods*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D010045:Outpatients; D019338:Polypharmacy; D012189:Retrospective Studies; D013624:Taiwan; D055815:Young Adult
Ann Emerg Med. 2001 Dec;38(6):666-71
11719747
Clin Geriatr Med. 2009 May;25(2):221-33
19555869
Br J Clin Pharmacol. 2007 Feb;63(2):187-95
16939529
Am J Geriatr Pharmacother. 2009 Apr;7(2):93-104
19447362
Ann Pharmacother. 2002 Nov;36(11):1675-81
12398558
J Pharm Pharm Sci. 2006;9(3):427-33
17207423
J Clin Pharm Ther. 2007 Oct;32(5):469-76
17875113
Pharmacotherapy. 2005 Nov;25(11):1636-45
16232025
J Gerontol Nurs. 2005 Sep;31(9):4-11
16190007
Int J Clin Pharmacol Ther. 2007 Dec;45(12):643-53
18184532
J Clin Pharm Ther. 2005 Feb;30(1):13-20
15659000
Lancet. 2007 Jul 14;370(9582):185-191
17630042
Am J Geriatr Pharmacother. 2007 Dec;5(4):345-51
18179993
Int J Clin Pharmacol Ther. 2000 Nov;38(11):504-13
11097142
Pharmacoepidemiol Drug Saf. 2006 Mar;15(3):179-84
16184621
Drug Saf. 2007;30(10):911-8
17867728
J Clin Pharm Ther. 2009 Aug;34(4):377-86
19583670
BMJ. 2001 Aug 25;323(7310):427-8
11520839
Am J Manag Care. 2004 Nov;10(11 Pt 1):753-9
15623265
Am J Geriatr Pharmacother. 2006 Jun;4(2):134-43
16860260
Drugs Aging. 2008;25(2):145-52
18257601
Drug Saf. 2006;29(1):79-90
16454536
Drugs Aging. 2008;25(8):683-92
18665660
BMC Psychiatry. 2005 May 27;5:26
15921508
Drugs Aging. 2007;24(5):429-40
17503898
J Gerontol A Biol Sci Med Sci. 2006 May;61(5):511-5
16720750
J Am Acad Nurse Pract. 2005 Apr;17(4):123-32
15819637
Nurse Pract. 2005 Jun;30(6):44-50
15944473
Drugs Aging. 2008;25(4):343-55
18361544
Int J Clin Pharmacol Ther. 2006 Nov;44(11):539-47
17176620
Expert Opin Drug Saf. 2007 Nov;6(6):695-704
17967158